Insulet Corporation
Could not find a ticker for this position, may be a filing error
A maker of the Omnipod, a tubeless, wearable insulin pump worn on the skin that lets people with diabetes manage their insulin without daily injections or tubing. The company was founded in 2000 after co-founder John Brooks' young son was diagnosed with type 1 diabetes, and its name blends "insulin" and "let." Legend has it Brooks first sketched the device's design on a napkin aboard an airplane.
3.75% Convertible Senior Notes due 2016
Granted 1.7K
Granted 1.7K
Granted 1.7K
Bought 1.1K
Granted 1.7K · Bought 3.5K
Granted 1.7K · Bought 2.8K
Granted 1.7K · Sold 418
Granted 1.7K
Granted 1.8K
Granted 2.8K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Minogue Michael RDirector · 1 transaction | +3.7% | 47.0K | 1.7K | — | — |
| Scannell Timothy JDirector · 1 transaction | +5.3% | 33.0K | 1.7K | — | — |
| Hopfield JessicaDirector · 1 transaction | +6% | 29.4K | 1.7K | — | — |
| McEvoy AshleyPresident and CEO, Director · 2 transactions | -1% | 23.7K | — | 1.1K | — |
| Weatherman Elizabeth HDirector · 2 transactions | +97.5% | 10.4K | 1.7K | 3.5K | — |
| Stonesifer Timothy C.Director · 2 transactions | +96.9% | 9.0K | 1.7K | 2.8K | — |
| Borio LucianaDirector · 2 transactions | +40.2% | 4.3K | 1.7K | — | 418 |
| Frederick Wayne A.I.Director · 1 transaction | +76.9% | 3.8K | 1.7K | — | — |
| Huffines Robert LutherDirector · 2 transactions | +335.4% | 2.3K | 1.8K | — | — |
| Panos MichaelEVP and CCO · 1 transaction | — | 5 | 2.8K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 6 months: +6.9K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.